CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 201 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 4
  • Male, aged 18 years or older
  • Discussion of urinary symptoms with primary care provider between 15 days and 12 months before phone interview
  • Able to read, speak, and understand English
  • Willing to provide informed consent and authorize release of medical records for past 12 months
Key exclusion· 5
  • First-ever discussion of urinary symptoms with PCP within 14 days prior to phone interview
  • Participation in clinical research study evaluating urinary symptoms in past 12 months
  • Self-reported history of colorectal, bladder, or prostate cancer
  • Self-reported neurologic disorders affecting bladder function (e.g., spinal cord injury/disease, multiple sclerosis, Parkinson's disease)

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03075449
NCT03075449N/ACompleted

Real World Data Exploring the Practices of Primary Care Providers in the Managment of Male Lower Urinary Tract Symptoms

Boehringer Ingelheim·observational·Posted Mar 9, 2017·Updated Mar 26, 2020

In Brief

An observational study for Benign Prostatic Hyperplasia. Completed, enrolled 201 participants across 1 site.

Detailed Summary

This study will describe the current medical care given to men who discuss their lower urinary tract symptoms with a HCP. It will document the primary reasons for the visit, the baseline characteristics of these men, the treatment received, and the practice patterns of specifically a primary care physician managing these patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 9, 2017
Enrollment StartMay 19, 2016
Primary CompletionDec 21, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 9.3 years ago